Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Dec 14;17(46):5117-22.
doi: 10.3748/wjg.v17.i46.5117.

Aspirin-induced small bowel injuries and the preventive effect of rebamipide

Affiliations
Randomized Controlled Trial

Aspirin-induced small bowel injuries and the preventive effect of rebamipide

Kazuhiro Mizukami et al. World J Gastroenterol. .

Abstract

Aim: To evaluate the influence of taking low-dose aspirin for 4 wk on small intestinal complications and to examine the preventive effect of rebamipide.

Methods: This study was conducted as a single-center, randomized, double-blind, cross-over, placebo-controlled study. Eleven healthy male subjects were enrolled. Each subject underwent video capsule endoscopy after 1 and 4 wk of taking aspirin and omeprazole, along with either rebamipide or placebo therapy. The primary endpoint was to evaluate small bowel damage in healthy subjects before and after taking low-dose aspirin for 4 wk.

Results: The number of subjects with mucosal breaks (defined as multiple erosions and/or ulcers) were 1 at 1 wk and 1 at 4 wk on the jejunum, and 6 at 1 wk (P = 0.0061) and 7 at 4 wk on the ileum (P = 0.0019). Rebamipide significantly prevented mucosal breaks on the ileum compared with the placebo group (P = 0.0173 at 1 wk and P = 0.0266 at 4 wk).

Conclusion: Longer-term, low-dose aspirin administration induced damage in the small bowel. Rebamipide prevented this damage, and may be a candidate drug for treating aspirin-induced small bowel complications.

Keywords: Capsule endoscopy; Healthy subjects; Low-dose aspirin; Rebamipide; Small bowel injury.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study design.
Figure 2
Figure 2
Typical small intestinal red spot, erosion and ulcer. A: Typical red spot; B: Typical erosion; C: Typical ulcer.
Figure 3
Figure 3
Low-dose aspirin-related small bowel injuries in the placebo group. The open circle indicates the number of low-dose aspirin-related small bowel injuries in the jejunum, and the closed circle indicates the number of injuries in the ileum at 4 wk. The data are represented as the mean ± SD. aP < 0.05, bP < 0.01.
Figure 4
Figure 4
Case with a large ulcer of the small intestine induced by low-dose aspirin. A large ulcer was observed in the small intestine as a result of 4 wk of low-dose aspirin ingestion. The ulcer occupied one-third of the interior of the small intestine.

References

    1. Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature. 2000;405:417. - PubMed
    1. Gong F, Swain P, Mills T. Wireless endoscopy. Gastrointest Endosc. 2000;51:725–729. - PubMed
    1. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3:55–59. - PubMed
    1. Mehta P. Aspirin in the prophylaxis of coronary artery disease. Curr Opin Cardiol. 2002;17:552–558. - PubMed
    1. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116:4–15. - PMC - PubMed

Publication types

MeSH terms